Clinical Trial Update: Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioavailability study comparing a modified-release formulation of apixaban with the immediate-release tablet was completed in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Pfizer | Conditions: Thrombosis | Phase 1 | Status: COMPLETED